BioSpace News Archive

First Wave BioPharma Provides Update on Adrulipase (FW-EPI) Clinical Program

First Wave BioPharma, Inc., today provided an update on its adrulipase (FW-EPI) clinical program and advances involving adrulipase.

January 13, 2022
·
7 min read
Business

PacBio Names Lara Toerien as Vice President and General Manager for the AmericasIndustry Veteran Will Lead Company’s Commercial Growth Strategy in Americas Region

PacBio welcomes Lara Toerien, Ph.D., as Vice President and General Manager for the company’s Americas region.

January 13, 2022
·
3 min read
Business

Journey Medical Corporation Acquires Two FDA-Approved Topical Minocycline Products and Molecule Stabilizing Technology (MST)™ Franchise from VYNE Therapeutics, Inc.

Journey Medical Corporation today announced that the company entered into a definitive agreement with VYNE Therapeutics, Inc.

January 13, 2022
·
9 min read
Pharm Country

VYNE Therapeutics Divests Topical Minocycline Assets

VYNE Therapeutics Inc. announced that it has sold its Molecule Stabilizing Technology franchise, including AMZEEQ® topical foam, 4%, and ZILXI® topical foam, 1.5%, to Journey Medical Corporation .

January 13, 2022
·
9 min read
Business

Tiziana Life Sciences Announces Death of Director

Tiziana Life Sciences today announced that Dr. Thomas Adams passed away on January 9, 2022.

January 13, 2022
·
1 min read
Business

OpSens Announces FIRST Quarter fiscal 2022 Financial Results

OpSens Inc. today reported its results for the first quarter of fiscal year 2022 ended November 30, 2021.

January 13, 2022
·
5 min read
Business

BridgeBio Announces Clinical Collaboration with Amgen to Study BBP-398, a Potentially Best-in-class SHP2 Inhibitor, in Combination with LUMAKRAS® (sotorasib) in Advanced Solid Tumors with the KRAS G12C Mutation

BridgeBio Pharma, Inc. today announced a non-exclusive clinical collaboration with Amgen Inc. (Amgen) to evaluate the combination of BBP-398.

January 13, 2022
·
6 min read
BioCapital

AstraZeneca Aims to Redefine Liver, Biliary Tract and Prostate Cancer Treatment With Practice-Changing IMFINZI® (durvalumab) and LYNPARZA® (olaparib) Data at ASCO GI and GU

AstraZeneca will present new data in liver, biliary tract and prostate cancers illustrating its ambition to revolutionize cancer care at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) and the 2022 ASCO Genitourinary Cancers Symposium (ASCO GU).

January 13, 2022
·
25 min read
Deals

Vonco Acquires Flex-Pak, Specialty Provider of DuPont™ Tyvek®, Expanding its Contract Manufacturing Capabilities and Services for Healthcare and Consumer Markets

Vonco Acquires Flex-Pak, Specialty Provider of DuPont™ Tyvek ® , Expanding its Contract Manufacturing Capabilities and Services for Healthcare and Consumer Markets.

January 13, 2022
·
3 min read
Drug Development

EDAP Announces Publication of Positive Pre-clinical Results Using Intraoperative HIFU Ablation of the Pancreas in the Journal Cancers

EDAP TMS SA today announces the publication of positive pre-clinical results using intraoperative high intensity focused ultrasound (HIFU) ablation of the pancreas in the peer-reviewed journal Cancers.

January 13, 2022
·
4 min read